MedTrace Logo

Carious Tissue Selective Removal on Permanent Posterior Teeth.

NCT04533113 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 111

Last updated 2020-08-31

No results posted yet for this study

Summary

This study is a prospective randomized controlled study of patients who come to the University. The aim is to evaluate the success rate of selective removal of carious tissue in deep lesions of posterior teeth. Three different materials will be used as liners (VitreBond ™Plus, BioDentine™, and Theracal™ LC). Post-operative pain, clinical, and radiographic success will be evaluated at one, two, and five-year follow-up. The null hypothesis is that there will be no statistically significant differences in rates of successful treatment with the three materials used.

Conditions

  • Dental Caries
  • Dental Materials

Interventions

PROCEDURE

Carious tissue selective removal

Carious tissue selective removal in deep carious lesions in posterior teeth, using one of three materials as a liner under the final composite restoration

Sponsors & Collaborators

  • Juan Gonzalo Olivieri

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-20
Primary Completion
2021-07-31
Completion
2026-07-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04533113 on ClinicalTrials.gov